Abstract:The immune system plays a central role in tissue repair and regeneration. Indeed, the immune response to tissue injury is crucial in determining the speed and the outcome of the healing process, including the extent of scarring and the restoration of organ function. Therefore, controlling immune components via biomaterials and drug delivery systems is becoming an attractive approach in regenerative medicine, since therapies based on stem cells and growth factors have not yet proven to be broadly effective in the clinic. To integrate the immune system into regenerative strategies, one of the first challenges is to understand the precise functions of the different immune components during the tissue healing process. While remarkable progress has been made, the immune mechanisms involved are still elusive, and there is indication for both negative and positive roles depending on the tissue type or organ and life stage. It is well recognized that the innate immune response comprising danger signals, neutrophils and macrophages modulates tissue healing. In addition, it is becoming evident that the adaptive immune response, in particular T cell subset activities, plays a critical role. In this review, we first present an overview of the basic immune mechanisms involved in tissue repair and regeneration. Then, we highlight various approaches based on biomaterials and drug delivery systems that aim at modulating these mechanisms to limit fibrosis and promote regeneration. We propose that the next generation of regenerative therapies may evolve from typical biomaterial-, stem cell-, or growth factor-centric approaches to an immune-centric approach.STATEMENT OF SIGNIFICANCE: Most regenerative strategies have not yet proven to be safe or reasonably efficient in the clinic. In addition to stem cells and growth factors, the immune system plays a crucial role in the tissue healing process. Here, we propose that controlling the immune-mediated mechanisms of tissue repair and regeneration may support existing regenerative strategies or could be an alternative to using stem cells and growth factors. The first part of this review we highlight key immune mechanisms involved in the tissue healing process and marks them as potential target for designing regenerative strategies. In the second part, we discuss various approaches using biomaterials and drug delivery systems that aim at modulating the components of the immune system to promote tissue regeneration.

Unravelling & Harnessing The Immune Response at The Cell‐Biomaterial Interface for Tissue Engineering Purposes.

Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering

Biomaterials: Foreign Bodies or Tuners for the Immune Response?

Immunomodulatory Biomaterials: Tailoring Surface Properties to Mitigate Foreign Body Reaction and Enhance Tissue Regeneration

Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine

Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering

Toward a Better Regeneration Through Implant-Mediated Immunomodulation: Harnessing the Immune Responses.

Engineering Immunomodulatory Biomaterials To Tune the Inflammatory Response

Advanced Immunomodulatory Biomaterials for Therapeutic Applications

Modulation of immune-inflammatory responses through surface modifications of biomaterials to promote bone healing and regeneration

Osteoinduction and osteoimmunology: Emerging concepts

Current Advances in Immunomodulatory Biomaterials for Cell Therapy and Tissue Engineering

Advanced Strategies for Modulation of the Material–Macrophage Interface

Insights into the use of genetically modified decellularized biomaterials for tissue engineering and regenerative medicine

Promoting tissue regeneration by modulating the immune system

Bio-Responsive Materials For Tissue Regeneration

Conserved and tissue-specific immune responses to biologic scaffold implantation

Current Advances in Immunomodulatory Biomaterials for Bone Regeneration

Monocytes and macrophages in tissue repair: Implications for immunoregenerative biomaterial design

The State of the Art and Prospects for Osteoimmunomodulatory Biomaterials

Conjugation of IL‐33 to Microporous Annealed Particle Scaffolds Enhances Type 2‐Like Immune Responses in Vitro and in Vivo